NM_001034853.2(RPGR):c.1872_1873del (p.Glu624AspfsTer5) is a frameshift variant due to a two-nucleotide deletion that introduces a premature stop codon within exon 15 of 15 that is predicted to disrupt a critical C-terminal region required for proper function of RPGR (PVS1, PMID: 36445968). This variant is absent from hemizygous individuals in gnomAD v4.1.0 (PM2_Supporting). At least one proband harboring this variant exhibits a phenotype including early onset (1 pt), night blindness (0.5 pts), electroretinogram responses consistent with retinitis pigmentosa, and reduced visual fields (0.5 pts), with genotyping by next-generation sequencing identifying no alternative basis for retinal disease (2 pts), which together are specific for RPGR-related retinopathy (4 points, ClinVar Accession: SCV001427266.1, PP4). This variant has been reported in at least 1 proband meeting one of the PS4 requirements of some functional vision impairment in affected males by age 30 years, and/pr decreased or absent electroretinogram responses (PMID: 34745198), in addition to the proband previously used to meet the PP4 code (ClinVar Accession: SCV001427266.1) (PS4_Supporting). This variant has been reported in at least 6 other apparently unrelated probands (PMID: 34985506, PMID: 37217489, PMID: 12657579, PMID: 12402343, PMID: 32531858, PMID: 30902645, ClinVar Accession: SCV001427266.1) who were not described in sufficient detail for inclusion in PS4. The variant has been reported to segregate with retinal dystrophy through an affected mother and son (PP1; PMID: 34745198). In summary, this variant is classified as pathogenic for RPGR-related retinopathy based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RPGR Version 1.0.0; PVS1, PM2_Supporting, PP4, PS4_Supporting, and PP1.